Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort (Q37349771)
Jump to navigation
Jump to search
scientific article published on 06 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort |
scientific article published on 06 September 2013 |
Statements
1 reference
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort (English)
1 reference
Stefan Braune
1 reference
M Lang
1 reference
A Bergmann
1 reference
NTC Study Group
1 reference
1 reference
6 September 2013
1 reference
Identifiers
1 reference